DNA and RNA Vaccines: Current Status, Quality Requirements and Specific Aspects of Preclinical Studies
This review focuses on DNA and RNA vaccines whose potential use was first considered at the end of the 20th century. However, not a single bacterial plasmid-based or mRNA vaccine has been used since that time in public healthcare for the prevention of infectious diseases. Nevertheless, vaccines cont...
Saved in:
| Main Authors: | A. A. Goryaev, M. V. Savkina, Yu. I. Obukhov, V. A. Merkulov, Yu. V. Olefir |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2019-06-01
|
| Series: | Биопрепараты: Профилактика, диагностика, лечение |
| Subjects: | |
| Online Access: | https://www.biopreparations.ru/jour/article/view/218 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunogenicity of DNA, mRNA and Subunit Vaccines Against Beak and Feather Disease Virus
by: Buyani Ndlovu, et al.
Published: (2025-07-01) -
Advances in nucleic acid-based cancer vaccines
by: Hung-Chun Liao, et al.
Published: (2025-01-01) -
Nucleic acid vaccines: innovations, efficacy, and applications in at-risk populations
by: Emily N. Konopka, et al.
Published: (2025-05-01) -
Delineation of DNA and mRNA COVID-19 vaccine-induced immune responses in preclinical animal models
by: Viviane M. Andrade, et al.
Published: (2023-12-01) -
Development of mRNA rabies vaccines
by: Zixin Fang, et al.
Published: (2024-12-01)